文献速递淋巴瘤

皮肤T细胞淋巴瘤的遗传与表观遗传学见解

Genetic and epigenetic insights into cutaneous T-cell lymphoma.
PubMed 文献 · Blood · 2022-01-01

本文综述近年二代测序等技术推动下对皮肤T细胞淋巴瘤(CTCL)遗传与表观遗传学改变的认识进展。研究发现不同CTCL亚型间存在广泛异质性,同时各诊断亚群具有高度特征性的反复出现的基因改变,涉及表观遗传重塑、细胞周期调控及致癌通路组成性激活。异常JAK-STAT信号是反复出现的主题,但并非所有CTCL共有,且在不同病种中原因似有不同。

要点

  • 不同CTCL亚型间遗传与表观遗传改变存在广泛异质性。
  • 各诊断亚群具有高度特征性的反复基因改变。
  • 异常JAK-STAT信号反复出现但非所有CTCL共有。

核心结论

  • CTCL各亚型在遗传与表观遗传层面存在广泛异质性,同时具有亚群特征性的反复改变,部分改变为潜在可靶向靶点。

研究设计与样本

  • 综述类:汇总二代测序等技术对明确诊断实体CTCL的遗传、表观遗传及转录变化的分析结果。

主要发现

  • 不同CTCL亚型之间异质性广泛,同时识别出对诊断亚群高度特征的反复改变。
  • 已识别改变主要涉及表观遗传重塑、细胞周期调控和可靶向致癌通路的组成性激活。
  • 异常JAK-STAT信号反复出现,但并非所有CTCL共有,且在不同病种中原因似有不同。
  • 部分突变基因为潜在可操作靶点,可用于开发新治疗策略。
  • 相关研究产生大量信息,对开发改进诊断与预后生物标志物具有关键意义。

临床怎么用

  • 上述改变有望辅助开发诊断与预后生物标志物,协助CTCL患者的临床管理。
  • 部分突变基因为潜在可靶向靶点,可支持新型治疗策略的开发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Primary cutaneous T-cell lymphomas (CTCLs) constitute a heterogeneous group of non-Hodgkin T-cell lymphomas that present in the skin. In recent years, significant progress has been made in the understanding of the pathogenesis of CTCLs. Progress in CTCL classifications combined with technical advances, in particular next-generation sequencing, enabled a more detailed analysis of the genetic and epigenetic landscape and transcriptional changes in clearly defined diagnostic entities. These studies not only demonstrated extensive heterogeneity between different CTCL subtypes but also identified recurrent alterations that are highly characteristic for diagnostic subgroups of CTCLs. The identified alterations, in particular, involve epigenetic remodeling, cell cycle regulation, and the constitutive activation of targetable oncogenic pathways. In this respect, aberrant JAK-STAT signaling is a recurrent theme; however, it is not universal for all CTCLs and has seemingly different underlaying causes in different entities. A number of the mutated genes identified are potentially actionable targets for the development of novel therapeutic strategies. Moreover, these studies have produced an enormous amount of information that will be critically important for the further development of improved diagnostic and prognostic biomarkers that can assist in the clinical management of patients with CTCL. In the present review, the main findings of these studies in relation to their functional impact on the malignant transformation process are discussed for different subtypes of CTCLs.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Tensen CP, Quint KD, Vermeer MH, et al. Genetic and epigenetic insights into cutaneous T-cell lymphoma. Blood. 2022. PMID: 34570882. doi:10.1182/blood.2019004256

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。